Europe
Crescendo Biologics Limited scores £17.5m in its Series A round
Crescendo Biologics was able to gather £17.5 million or $28 million from lead investor Imperial Innovations for its Series A round. Astellas Venture Management and Sofinnova Partners also participated in the financing.
Barclays asks judge to stop regulator from collecting fines
UK-based lender Barclays denied allegations that it manipulated electricity prices in California. It asked the the court to stop the US Federal Energy Regulatory Commission from collecting fines.
Telecom Italia rebel investor submits list of candidates for new board
Shareholders of Italian telecom company Telecom Italia are were said to vote this week on whether or not to oust its current board. Rebel investor Findim Group on Monday proposed candidates for Telecom Italia's new board.
Study says deals M&A deals among wealth managers increase this year
A study from Scorpio Partnership, a consultancy group based in London, showed that mergers and acquisitions among wealth managers have gone up this year, Bloomberg reported.